Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Tipo de estudio
Intervalo de año
1.
An. bras. dermatol ; 92(5,supl.1): 34-36, 2017. graf
Artículo en Inglés | LILACS | ID: biblio-887060

RESUMEN

Abstract: Bullous pemphigoid is a blistering autoimmune disease characterized by two hemidesmosomal proteins (anti-BP180 and 230). Pemphigus, by contrast, is characterized by two autoantibodies (anti-desmoglein 1 and 3). Coexistence of autoantibodies of bullous pemphigoid and pemphigus in a patient is rare. A 25-year-old male patient was admitted to our hospital, reporting a 3-month history of multiple papules, vesicles, and erosions over an extensive erythema on the entire body. Laboratory tests showed high levels of serum IgE, anti-BP180 antibodies, and anti-desmoglein 1 and 3. Histopathologic and immunopathologic features were characterized by bullous pemphigoid. No improvement was seen with systemic corticosteroid therapy, however, pulse corticosteriod therapy combined with methylprednisolone, immunosuppressants, immunomodulators, and plasmapheresis led to the recovery of his condition with numerous milia.


Asunto(s)
Humanos , Masculino , Adulto , Inmunoglobulina E/sangre , Penfigoide Ampolloso/inmunología , Penfigoide Ampolloso/patología , Desmogleínas/inmunología , Queratosis/inmunología , Queratosis/patología , Piel/patología , Autoanticuerpos/sangre , Autoantígenos/sangre , Biopsia , Metilprednisolona/uso terapéutico , Penfigoide Ampolloso/tratamiento farmacológico , Colágenos no Fibrilares/sangre , Úlcera por Presión/patología , Glucocorticoides/uso terapéutico , Queratosis/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA